Diagnosis and investigation of essential and secondary hypertension

European Heart Journal

Volumn 19, Issue 3, 1998, Pages 372-377

  Mayet, J ^a   Coats, A J S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BORDERLINE HYPERTENSION; DISEASE CLASSIFICATION; ESSENTIAL HYPERTENSION; HYPERTENSION; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; HYPERTENSION, RENOVASCULAR;

EID: 0032032268     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0595     Document Type: Review

References (28)

1. [1] Collins R, Peto R, McMahon S et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
2. [2] McMahon S, Peto R, Cutler J et al. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet 1990; 335: 765-74.
3. [3] Evans JG, Pose G. Hypertension. Br Med Bull 1971; 27: 37-42.
4. [4] Petrie JC, O'Brien ET, Littler WA, de Swiet M. Blood pressure measurement. London: Br Med J, 1987.
5. [5] O'Brien E, Atkins N, Mee F, Coyle D, Syed S. A new audiovisual technique for recording blood pressure in research? The sphygmocorder. J Hypertens 1995; 13: 1734-7.
6. [6] Smith TDW, Clayton D. Individual variation between general practitioners in labelling of hypertension. Br Med J 1990; 300: 74-5.
7. [7] Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97-104.
8. [8] Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143-52.
9. [9] Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-71.
10. [10] Australian National Blood Pressure Management Committee. The Australian Therapeutic trial in mild hypertension. Lancet 1980; I: 1261-7.
11. [11] SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 255-64.
12. [12] Medical Research Council Working Party. MRC trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-12.
13. [13] Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham study. Circulation 1986; 61: 1179-82.
14. [14] 1993 guidelines for the management of hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11: 905-18.
15. [15] The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-83.
16. [16] Pickering TG. Blood pressure measurement and detection of hypertension. Lancet 1994; 344: 31-5.
17. [17] Gosse P, Promax H, Durandet P, Clementy J. 'White coat' hypertension: no harm for the heart. Hypertension 1993; 22: 766-9.
18. [18] Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989; 7 (Suppl 3): S3-S10.
19. [19] Verdecchia P, Porcellati C, Schillaci G et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
20. [20] Staessen JA, O'Brien ET, Atkins N, Amery AK. Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens 1993; 11: 1289-97.
21. [21] Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992; 10: 385-91.
22. [22] Kannel WB. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J 1992; 13 (Suppl D): 82-8.
23. [23] Devereux RB, Koren MJ, De Simone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993; 14 (Suppl D): 8-15.
24. [24] Sever PS, Beevers G, Bulpitt C et al. Management guidelines in essential hypertension: report of the second working part of the British Hypertension Society. Br Med J 1993; 306: 983-7.
25. [25] Dahlof B, Lindholm LH, Hansson L, Scherston B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.
26. [26] Streeten DH, Anderson GH. Secondary hypertension. An overview of its causes and management. Drugs 1992; 43: 805-19.
27. [27] Mann SJ, Pickering TG. Detection of renovascular hypertension. State of the art: 1992. Ann Intern Med 1992; 117: 845-53.
28. [28] National High Blood Pressure Education Program Working Group. 1995 update of the working group reports on chronic renal failure and renovascular hypertension. Arch Intern Med 1996; 156: 1938-47.